MedPath

Making Memory Better for Seniors With Mild Cognitive Impairment

Not Applicable
Active, not recruiting
Conditions
Mild Cognitive Impairment
Registration Number
NCT01532739
Lead Sponsor
Nova Scotia Health Authority
Brief Summary

The purpose of this study is to investigate the feasibility and effectiveness of a cognitive training group in individuals with Mild Cognitive Impairment, using a new paradigm that will optimize ecological validity by (1) focusing on everyday memory problems, (2) supplementing traditional memory training with the teaching of an empirically-supported problem-solving approach, and (3) employing a clinically representative sample of individuals with MCI (e.g., not excluding those with mild affective symptoms).

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Clinical diagnosis of Mild Cognitive Impairment
Exclusion Criteria
  • Clinical diagnosis of dementia
  • History of neurological conditions known to impair cognition
  • History of alcohol or drug abuse
  • History of chronic psychiatric illness
  • Current symptoms of moderate to severe depression (Geriatric Depression Scale >19) or anxiety (Beck Anxiety Inventory >15)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Change in everyday memory functioningMeasured at baseline and months 3, 5, 8

Rivermead Behavioural Memory Test (3rd Edition)

Secondary Outcome Measures
NameTimeMethod
Change in memory perceptionMeasured at baseline and months 3, 5, 8

Multifactorial Metamemory Questionnaire

Change on traditional memory testingMeasured at baseline and months 3, 5, 8

California Verbal Learning Test (2nd Edition)

Change in quality of lifeMeasured at baseline and months 3, 5, 8

Zarit Burden Interview

Change in mood (i.e., self-report symptoms of depression)Measured at baseline and months 3, 5, 8

Geriatric Depression Scale

Change in mood (i.e., self-report symptoms of anxiety)Measured at baseline and months 3, 5, 8

Beck Anxiety Inventory

FeasibilityMeasured at end of study

Recruitment, retention, and compliance rates

Change in other psychiatric symptoms (informant-report)Measured at baseline and months 3, 5, 8

Neuropsychiatric Inventory

Change in caregiver burdenMeasured at baseline and months 3, 5, 8

Zarit Burden Interview

Trial Locations

Locations (1)

Neuropsychology Service, Nova Scotia Hospital

🇨🇦

Dartmouth, Nova Scotia, Canada

Neuropsychology Service, Nova Scotia Hospital
🇨🇦Dartmouth, Nova Scotia, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.